Skip to main content
XRTX
NASDAQ Life Sciences

XORTX Therapeutics Prices $5M Public Offering, Highly Dilutive

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$2.04
Mkt Cap
$3.258M
52W Low
$1.725
52W High
$7.05
52W Position info
18% above low
Off High info
71% below high
Rel. Volume
Market data snapshot near publication time

XRTX sits 18% above its 52-week low of $1.725.

Summary

XORTX Therapeutics Inc. announced the pricing of a $5 million public offering at $1.88 per share or pre-funded warrant, representing significant dilution for existing shareholders.


Key Events · Financing and Capital Events · XRTX

  • Public Offering Priced

    XORTX Therapeutics announced the pricing of a public offering to raise $5 million in gross proceeds.

  • Significant Dilution

    The offering involves 2,659,574 common shares or pre-funded warrants at $1.88 each, representing over 150% of the company's current market capitalization.

  • Discounted Pricing

    The offering price of $1.88 per share is at a discount to the current stock price of $2.04.

  • Pre-Funded Warrants Included

    The offering includes pre-funded warrants with an exercise price of $0.0001, immediately exercisable.


Analysis · XRTX · Life Sciences

This $5 million public offering, priced at a discount to the current market price, is highly dilutive, representing over 150% of the company's current market capitalization. While it provides critical capital for a company that has previously issued "going concern" warnings, the terms indicate a substantial cost to existing equity holders. The offering includes pre-funded warrants, which further adds to potential future dilution.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, XRTX was trading at $2.04 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $1.73 to $7.05. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XRTX - Latest Insights

XRTX
Nov 13, 2026, 9:21 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.01
Real-time Price: $0.839 info
Change: -$0.172 (-17%) info
Market Cap: $1.885M info
XRTX
Oct 08, 2026, 4:00 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.33
Real-time Price: $0.839 info
Change: -$1.49 (-64%) info
Market Cap: $1.885M info
XRTX
Sep 18, 2026, 8:05 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.76
Real-time Price: $0.839 info
Change: -$0.9254 (-52%) info
Market Cap: $1.885M info
XRTX
Sep 18, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.68
Real-time Price: $0.839 info
Change: -$0.841 (-50%) info
Market Cap: $1.885M info
XRTX
Sep 04, 2026, 8:51 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.39
Real-time Price: $0.839 info
Change: -$1.55 (-65%) info
Market Cap: $1.885M info